Search results
ESC 23: The RIGHT Study
Author(s):
Yan Yan
,
Gilles Montalescot
Added:
7 months ago
Video
Author(s):
Erik B Friedrich
,
Michael Böhm
Added:
3 years ago
Chronic heart failure (CHF) is a major public health problem in industrialized societies with an incidence approaching 10 per 1,000 population after age 65 and an age-dependent prevalence of less than 1% between ages 45-55, 2-5% between ages 65-75, and approximately 10% for patients aged 80 years or more.Thus, HF is primarily a condition of the elderly and approximately 80% of patients…
View more
Author(s):
Gregory J Dehmer
Added:
3 years ago
In what is often cited as the earliest public reporting of healthcare information, Florence Nightingale published mortality rates at British military hospitals caring for casualties of the Crimean War.1 Dr Ernest Codman, about 50 years later, called for the public release of surgical outcomes at his hospital, but was highly criticized for his effort eventually leading to the loss of his hospital…
View more
Author(s):
Rafael Romaguera
Added:
2 years ago
In this short interview, Dr Rafael Romaguera (University of Barcelona, SP) discusses the findings from the SUGAR trial.This randomized head-to-head trial aimed to compare Cre8 EVO stents to a contemporary drug-eluting stent (DES) in patients with diabetes (DM) and coronary artery disease. The trial, first presented at TCT 2021, demonstrated that Cre8 EVO stents were non-inferior to Resolute Onyx…
View more
Author(s):
Robert A Byrne
Added:
7 months ago
ESC 2023 — Dr Robert Byrne (Mater Private Hospital, Dublin, IE) joins us on-site to discuss the new guidelines from the ESC covering the management of acute coronary syndromes.
Acute Coronary Syndrome (ACS) is a broad spectrum of conditions, and the presentation can vary from a stable patient, to a patient who is critically ill. In the past, separate guidelines were issued for ST-Elevation…
View more
Author(s):
William Fearon
Added:
2 years ago
In this short interview, Dr William F Fearon (Stanford University School of Medicine, US) discusses the findings from the FAME3 trial. This multicenter, international, randomized, controlled noninferiority trial investigated whether fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) in patients with multivessel coronary artery disease (CAD) will result in similar…
View more
Author(s):
Stefan Stortecky
Added:
4 months ago
AHA 23 — We are joined onsite by Prof Stefan Stortecky (Bern University Hospital, Bern, SE) to discuss the findings of the single centre SPECIAL trial that investigated ultrasound-assisted catheter-directed thrombolysis as compared to surgical pulmonary embolectomy for intermediate high or high risk pulmonary embolism.Questions1. What is the reasoning behind this study?2. What is the patient…
View more
Author(s):
Aniket S Rali
,
Andrew J Sauer
Added:
3 years ago
In late December 2019, an outbreak of an unknown disease called a pneumonia of uncertain cause occurred in Wuhan, Hubei Province, China.1 Over the next few days, several independent laboratories identified the causative agent as a novel coronavirus.2–4 The WHO has temporarily named this virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), and the related infectious disease…
View more
Author(s):
Alexander G Truesdell
,
Rhian E Davies
,
Moemen Eltelbany
,
et al
Added:
11 months ago
Author(s):
Erik B Friedrich
,
Michael Böhm
Added:
3 years ago
Chronic heart failure (CHF) is a major public health problem in industrialized societies, with an incidence approaching 10 per 1,000 population after age 65 and an age-dependent prevalence of less than 1% between ages 45 and 55, 2-5% between ages 65 and 75, and approximately 10% for patients aged 80 years or more.1-3 Thus, HF is primarily a condition of the elderly, and approximately 80% of…
View more